Publication | Closed Access
CTONG 1509: Phase III study of bevacizumab with or without erlotinib in untreated Chinese patients with advanced EGFR-mutated NSCLC
55
Citations
0
References
2019
Year
No additional data available for this publication yet. Check back later!